Pulse Biosciences, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 11.93 million compared to USD 9.2 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 0.25 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.45 USD | +7.19% | -4.73% | -39.13% |
09/05 | Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System | CI |
07/05 | Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
1st Jan change | Capi. | |
---|---|---|
-39.13% | 411M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- Pulse Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023